Twist Bioscience Expands High-Throughput Antibody Characterization with Launch of Express Screening Antibodies
Twist Bioscience launched Twist Express Screening Antibodies, a high-throughput cell-free offering producing purified full-length IgG with SPR binding characterization. The workflow can assess thousands of antibodies per day with turnaround starting at five days, aimed at supporting AI/ML-driven antibody discovery workflows.
Key figures
- Turnaround days
- 5
- Antibody quantity range
- 5 μg to 20 μg
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.